谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Circulating Hallmarks of Hyperprogression in NSCLC Upon 1st Line PD-(L)1 Inhibitors Alone or in Combination with Chemotherapy

R. Ferrara, T. Torelli,M. Brambilla,A. Prelaj,C. M. Ciniselli, A. Piva,B. Bassani,E. Jachetti,G. Calareso,V. Duroni,C. Proto,S. Manglaviti,L. Mazzeo,T. Beninato,M. Ganzinelli,A. Bulotta,P. Verderio,B. Ricciuti, C. Bonini,M. C. Garassino, M. P. Colombo, V. Torri,L. Agnelli,G. Lo Russo,S. Sangaletti

JOURNAL OF THORACIC ONCOLOGY（2024）

引用 0|浏览2
关键词
Hyperprogressive disease,circulating biomarkers,immunotherapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要